Clinical decision support

Trained on 500,000 pathology slides, the AI predicts cancer type, treatment response, and survival with over 95% accuracy within minutes.

PredicTx expands clinical trial from Australia to India and the Middle East while working towards TGA approval and CE marking.

Care GP CEO Melvin Chen discusses how the company is rolling out its platform nationwide.

VUNO, Kakao Healthcare, Skylabs, and Remidio advance into Europe with partnership deals and regulatory approvals for AI in cardiac, chronic, and eye care.

Its chest X-ray analysis AI tool is the first to receive Europe's clearance for use in children aged 0-3.

Karthik Raja, Ascension's chief analytics and AI officer, says that AI success demands dual goals: pursue inspiring moonshots, but start with "quick wins" that solve daily pain points and drive efficiencies.

Also, a new AI-driven genomics platform developed in Queensland can identify cancer biomarkers and predict tumour responses to chemotherapy.

Also, health IT company UCrest from Malaysia has received its first patent for its AI-powered digital platform from Taiwan.

Julie Frey, VP of product at Wolters Kluwer Health, discusses how the company's clinical decision support tool, which combines trusted evidence with generative AI, fits into clinical workflows and augments physicians' judgment.

Developed with Murdoch Children's Research Institute, the AI has shown 90% detection accuracy.